Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The pursuit of academic knowledge can be its own reward. But for many researchers, the ultimate payback from their ideas and insights comes from forming a company to commercialize them. This Nature Outlook profiles the four companies selected as finalists for The Spinoff Prize 2024, as well as the seven that made the longlist. All 11 companies were recognized by the panel of judges as having extraordinary potential to develop science-based products or services that will change the way people live and work.
Getting molecules into cells using viral vectors or electroporation is expensive and laborious. The winner of the Spinoff Prize 2024 is showing that laser-heated nanoparticles could be an alternative solution.
Longitudinal evaluation of the Biomedical Entrepreneurship Educational Program suggests the program successfully educates and inspires the next generation of life science and biotechnology innovators.
Biotech startups benefit society by solving unmet scientific and medical needs, but more can be done to move their technologies to market more quickly.
Collaborations between researchers and companies can progress swimmingly and teams quickly validate findings and mature methods. All too often, things can’t advance and the ‘Valley of Death’ looms. New ways to collaborate, underpinned by computational muscle, can help.